BioMed Realty is a pioneer in providing real estate solutions specifically tailored to the unique needs of the life science and technology industries. As a portfolio company of Blackstone, they leverage deep financial expertise and market insight to manage over 17 million square feet of high-quality space, fostering environments where scientific breakthroughs and technological advancements can thrive.
The company operates a sophisticated development platform, focusing on Class A properties located in critical innovation hubs including Boston, San Francisco, San Diego, Seattle, and Boulder. By bridging the gap between sophisticated real estate development and the rigorous demands of laboratory and research-based tenants, BioMed Realty provides the vital infrastructure that powers the future of global science and technology.